This hernia mesh settlement amounts 2026 guide separates what has actually been paid or awarded from what is only estimated. Hernia mesh is not one litigation but three, and only one of them has settled — a distinction that changes what any given claim is worth.
Table of Contents
- What Are Hernia Mesh Settlements?
- The Bard Settlement: What Is and Isn’t Public
- Verdicts on the Record
- Reported Settlement Ranges
- Factors That Affect Your Settlement Value
- Who Qualifies
- Settlement Timeline
- Use the Settlement Calculator
- How a Settlement Is Actually Paid
- What to Gather Before You Call
- Common Misconceptions
- Frequently Asked Questions
Hernia Mesh Settlement Amounts: Key Facts for 2026
- Three separate litigations: Bard (MDL 2846), Covidien/Medtronic (MDL 3029) and Atrium/Getinge (MDL 2753). They are at different stages and are not interchangeable.
- Largest docket: Bard MDL 2846 before Judge Edmund A. Sargus Jr. in the Southern District of Ohio, with 23,321 actions pending as of August 2026.
- Bard has settled: Becton Dickinson announced a settlement framework in October 2024, reported to cover roughly 38,000 claims. No official settlement total has ever been disclosed.
- Covidien has not settled: MDL 3029 in the District of Massachusetts had 2,449 lawsuits and produced an $88 million verdict on 4 August 2026.
- Estimates are labelled: figures below are either matters of public record or clearly marked as reported estimates. No official per-claimant matrix has been published in any of the three litigations.
What Are Hernia Mesh Settlements?
A hernia mesh settlement is compensation paid to resolve a claim that a surgical mesh implant caused injury — typically adhesion, migration, erosion into bowel or organs, chronic pain, infection, recurrence of the hernia, or the need for revision surgery to remove or repair the device.
Because different manufacturers made different products, the claims were consolidated into separate federal proceedings rather than one. Which product was implanted determines which litigation a claim belongs to, and therefore what stage it is at:
- C.R. Bard / Davol (MDL 2846) — Southern District of Ohio, Judge Edmund A. Sargus Jr. The largest docket, and the only one with a global settlement framework in place.
- Covidien / Medtronic (MDL 3029) — District of Massachusetts. Bellwether trials began in 2026. No global settlement.
- Atrium Medical / Getinge (MDL 2753) — resolved through a confidential settlement, with a qualified settlement fund approved on 1 October 2024.
A claimant implanted with a Covidien product does not participate in the Bard settlement, and vice versa. Any figure quoted without naming the manufacturer should be treated as unreliable.
The Bard Settlement: What Is and Isn’t Public
This is the part most commonly misreported, so it is worth being precise.
What is confirmed: on 2 October 2024, Becton Dickinson — Bard’s parent company — announced an agreement to resolve the substantial majority of hernia mesh claims against Bard and Davol. The settlement is being administered under court-appointed special masters using a points-based system tied to injury severity and documentation. It has been reported to cover roughly 38,000 claims.
What has never been disclosed: the total value of the settlement. Becton Dickinson did not announce a capped figure. The frequently repeated “roughly $1 billion” is an estimate produced by plaintiffs’ attorneys working backwards from Becton Dickinson’s public financial reporting — not a disclosed or court-approved number.
What is reported but not published: that the highest tier of the points-based system has produced awards in the region of $900,000, with subsequent tiers considerably lower. This comes from attorney reporting rather than a published matrix. It should be read as an indication of structure, not as a figure any individual claimant is entitled to.
The practical consequence: a points-based settlement means individual outcomes turn on documentation. Two claimants with the same device and similar symptoms can land in different tiers if one has revision surgery records and pathology and the other does not.
Verdicts on the Record
Unlike settlement amounts, jury verdicts are public. These are the results actually returned in hernia mesh trials:
| Date | Case | Litigation | Result |
|---|---|---|---|
| 2021 | First Bard bellwether | Bard MDL 2846 | Defence verdict — Bard prevailed |
| April 2022 | Milanesi | Bard MDL 2846 | $255,000 for the plaintiff |
| November 2023 | Stinson | Bard MDL 2846 | $500,000 for the plaintiff |
| 4 August 2026 | Patterson | Covidien MDL 3029 | $88 million total — $77M to the plaintiff, $11M to his wife |
Two things about the Patterson verdict matter for anyone reading it as a benchmark. It was returned in the District of Massachusetts before Judge Patti B. Saris, in a case concerning a Symbotex mesh implanted in 2017 and the adequacy of the product’s warnings. And the jury declined to award punitive damages — the entire $88 million is compensatory.
A single verdict is not a settlement value. Verdicts are frequently reduced on post-trial motions or appeal, and bellwether results inform negotiations rather than setting a price. The gap between the $255,000 and $500,000 Bard bellwethers and the $88 million Covidien verdict reflects different defendants, different products, different evidence and different juries — not a rising scale.
Reported Hernia Mesh Settlement Amounts
No official per-claimant matrix has been published for any hernia mesh litigation, so the hernia mesh settlement amounts quoted publicly are reported figures rather than confirmed terms. The ranges discussed publicly are estimates compiled from attorney reporting and comparable resolutions, and they are presented here as such — not as figures anyone has been promised.
- Lower-tier claims — mesh implanted, complications documented, no revision surgery. Generally discussed as the lowest band in the points system, well below six figures.
- Mid-tier claims — documented revision or removal surgery, infection, or chronic pain with a clear treatment record.
- Highest-tier claims — bowel obstruction or perforation, organ damage, multiple revision surgeries, permanent impairment or death. Reported at approximately $900,000 at the top of the Bard structure.
What moves a claim between bands is documentation rather than description of symptoms. The points system rewards records: the operative report identifying the device, pathology from the explanted mesh, imaging, and a treatment history connecting the device to the injury.
Factors That Affect Your Settlement Value
- Which manufacturer and product — this determines the litigation and therefore whether a settlement framework even exists.
- Revision or removal surgery — the single strongest driver, because it converts a claim of harm into a documented surgical event.
- Severity of complication — bowel perforation, fistula, organ damage and sepsis sit at the top; localised pain without intervention sits at the bottom.
- Product identification — an operative report or device sticker naming the mesh. Without it, a claim may not qualify at all.
- Explant pathology — analysis of the removed mesh, where it exists.
- Economic loss — medical expenses, lost earnings and future care costs.
- Timing and limitation periods — deadlines run from diagnosis or discovery and vary by state.
Who Qualifies
Eligibility generally turns on four things: a hernia mesh device implanted, identification of the manufacturer and product, a documented complication attributed to the device, and a claim brought within the applicable limitation period.
Claims involving revision or removal surgery are the strongest, because the surgery itself creates the record. Claimants who have experienced complications but have not had corrective surgery may still qualify, though the evidentiary burden is heavier and the expected band lower.
Whether new claims can still join the Bard settlement framework depends on its eligibility criteria and the administration schedule. Covidien and Atrium claims follow entirely separate paths.
Settlement Timeline
For Bard claimants, the litigation stage is over and the administration stage has begun: claims are documented, scored under the points system, reviewed by special masters, and paid in sequence. Points-based administrations of this size typically run for a considerable period, and payment follows tier determination rather than filing date.
For Covidien claimants, the litigation is still active. The August 2026 Patterson verdict was the first plaintiff result, and further bellwether trials will shape any settlement discussions that follow. No settlement fund exists yet.
For Atrium claimants, a qualified settlement fund was approved on 1 October 2024 and the terms are confidential.
Use the Hernia Mesh Settlement Calculator
Want an organised view of the factors that affect your claim? Our free Hernia Mesh Settlement Calculator helps you assemble the device, surgical and damages information an attorney will ask for. It produces an educational estimate, not an offer.
How a Hernia Mesh Settlement Is Actually Paid
The Bard resolution is administered through a points-based system: a claimant’s file is scored against injury severity, the type of revision surgery required, product identity and other criteria, and the points determine the allocation. Becton Dickinson has never published the total value of the programme, and the points matrix itself is not public, which is why no honest source can tell you what a given claim is worth under it.
What is predictable is the shape of the deduction. From each allocation come, in order, the contingency fee and case expenses set out in the retainer agreement, then repayment of medical liens. Hernia mesh claimants often carry substantial liens, because the injuries at issue — revision surgery, bowel obstruction, chronic infection — generate large bills that a health insurer, Medicare or Medicaid has already paid. Those payers have a statutory or contractual right to be reimbursed from the settlement.
Lien amounts can frequently be reduced through formal resolution, but the process takes time. Across a programme covering roughly 38,000 claims, months typically pass between an agreed allocation and a distributed cheque. Anyone comparing hernia mesh settlement amounts should be clear whether the figure quoted is gross or net; most published figures are gross, and the difference is not small.
What to Gather Before Speaking to a Lawyer
Hernia mesh is unusual in that the first question is not how badly you were hurt, but whose product was implanted. Bard, Covidien and Atrium claims sit in three separate MDLs at three completely different stages: one has a settlement framework, one has just produced an $88 million verdict, and one has neither. A claim cannot be placed at all until the manufacturer is identified.
The document that settles it is the implant record — the product sticker or device log from the original hernia repair, which names manufacturer, model and lot number. If that is not in the records you hold, the hospital that performed the surgery will have it, and US hospitals are obliged to provide medical records on request, usually within thirty days.
Alongside product identification, the records that establish injury and loss matter: the operative report from the index repair, notes from any revision or explant surgery, imaging and diagnoses documenting adhesion, migration, erosion, obstruction, infection or recurrence, the treatment history, and documentation of lost earnings and future care.
Time is the other constraint. Limitation periods run from the date of injury or its discovery, vary by state, and are not extended by the existence of a settlement programme.
Common Misconceptions About Hernia Mesh Settlement Amounts
“Bard settled for $1 billion, so the average claim is worth about $26,000.”
Becton Dickinson has never disclosed a settlement total. The billion-dollar figure circulating online is an estimate inferred from BD’s financial statements by attorneys and analysts, not a published term. Dividing an inferred total by a claim count produces a number with two unknowns in it, and no claimant should plan around it.
“The $88 million verdict means my case is worth millions.”
The Patterson verdict was returned against Covidien, in a different MDL, on facts specific to one claimant — and the jury declined to award punitive damages, so the entire sum is compensatory. Large compensatory awards in product cases are routinely reduced on post-trial motions or appeal. A verdict sets a ceiling for negotiation; it does not set a value for other claims, least of all claims against a different manufacturer.
“All hernia mesh cases are part of one lawsuit.”
They are not. Bard sits in MDL 2846 before Judge Sargus in the Southern District of Ohio, Covidien in MDL 3029 in the District of Massachusetts, and Atrium in MDL 2753. Different defendants, different judges, different evidence, different stages. A settlement in one has no automatic effect on the others.
“If I have mesh, I have a claim.”
Most hernia repairs using mesh are uneventful, and mesh remains standard surgical practice. A viable claim needs an identified product from a defendant manufacturer, a documented complication, and treatment connecting the two — usually revision or explant surgery. Discomfort without documented complication is a difficult claim to bring.
“A settlement framework means every Bard claim gets paid.”
A framework establishes a process, not an entitlement. Claims still have to be documented, product identity still has to be established, and files that cannot show which mesh was implanted or what complication followed may be valued at little or nothing. Being inside a settlement programme and being paid a meaningful sum under it are two different things, and the points matrix that separates them has never been published.
“Atrium settled, so Atrium claims are resolved.”
A qualified settlement fund was approved in the Atrium litigation in October 2024. As with Bard, that establishes a vehicle for distributing money rather than a published set of hernia mesh settlement amounts. No per-claimant terms have been made public, and a fund can exist for a considerable period before allocations reach claimants.
Frequently Asked Questions
What is the average hernia mesh settlement amount?
There is no confirmed average, and the hernia mesh settlement amounts in circulation are reported estimates rather than published terms. The Bard settlement is administered through a points-based system whose total value was never disclosed, and no official per-claimant matrix has been published. Reported figures place the highest Bard tier around $900,000, with lower tiers considerably below that, but those are attorney reports rather than published terms.
How much was the Bard hernia mesh settlement?
Becton Dickinson never announced a figure. The widely cited “roughly $1 billion” is an estimate derived by attorneys from the company’s public financial reporting, not a disclosed or court-approved total. The framework was announced on 2 October 2024 and is reported to cover around 38,000 claims.
Does the $88 million verdict mean my case is worth millions?
No. The August 2026 Patterson verdict was a single jury result against Covidien in the District of Massachusetts, awarding $77 million to the plaintiff and $11 million to his wife, with no punitive damages. Verdicts are commonly reduced on post-trial motions or appeal, and they apply to one case on its own facts. They are not settlement values and do not apply to Bard claimants at all.
Which hernia mesh manufacturers are being sued?
The three principal federal proceedings involve C.R. Bard and Davol (MDL 2846), Covidien and Medtronic (MDL 3029), and Atrium Medical and Getinge (MDL 2753). Identifying the specific product implanted is the first step in any claim.
Can I still file a hernia mesh claim?
That depends on the manufacturer, which also determines whether any hernia mesh settlement amounts are available to you at all — only Bard has settled. the applicable state limitation period, and — for Bard — the eligibility criteria of the settlement administration. Deadlines generally run from the date of diagnosis or discovery of the injury, so timing matters.
Sources
Case counts, court identifiers and verdicts on this page are matters of public record. Where a figure is an estimate or an attorney report rather than a disclosed term, it is labelled as such above.
- Judicial Panel on Multidistrict Litigation — Pending MDL Dockets — source for pending action counts in MDL 2846, MDL 3029 and MDL 2753.
- U.S. District Court, Southern District of Ohio — the court administering Bard MDL 2846 before Judge Edmund A. Sargus Jr.
- U.S. Food and Drug Administration — Hernia Surgical Mesh Implants — federal regulatory background on mesh complications and recalls.
- Drugwatch — Hernia Mesh Litigation Status — settlement framework reporting, bellwether history and case counts.
Related Hernia Mesh Resources
- Hernia Mesh Lawsuit — eligibility, injuries and how claims are filed.
- Hernia Mesh Settlement Calculator — organise your device and treatment information.
- Medical Device Lawsuits — other active device litigation.
- Settlement Amounts — payout guides across all case types.
About the Author
Mason Arnao is a legal content strategist and mass tort researcher at TortAdvisor.com. He covers emerging litigation, settlement trends, and consumer legal rights across pharmaceutical, product liability, and personal injury law.
